Fibroheal Raises Debt Financing from BIRAC, Health News, ET HealthWorld

New Delhi: Fibroheal Woundcare has raised approximately $1 million in subprime debt financing from the Biotechnology Industry Research Assistance Council (BIRAC) under their PCP Fund (Product Commercialization Fund). ) and existing developers and investors.

The company intends to increase its go-to-market capabilities, bring more people on board and create impact through the economic multiplier potential of silk protein and the healing of different types of acute wounds, chronic, non-healing, slow-healing, difficult to heal, including postoperative wounds. wounds.

The company offers a range of products for different types and stages of wounds, including sheets, nets, foams, powder, particles and a range of adhesive dressings already marketed to date under the umbrella brand. “FIBROHEAL D-range”. .

The company has received early support from BIRAC and the Department of Biotechnology and has also been awarded BIRAC’s LEAP program and secured investments through CCAMP (Center for Cellular and Molecular Platforms).

Earlier in September 2021, KITVEN – Karnataka IT venture fund, the venture capital arm of the government of Karnataka, also made an investment of an undisclosed amount to expand its manufacturing capabilities to meet the increased demands expected from the market. Previously, they had raised funds from existing promoters, Telama Investments, CCAMP and KITVEN.

Comments are closed.